Plunkett Research Online: Tesaro Inc

TESARO INC (TSRO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. It has in-licensed and are currently developing two product candidates, rolapitant and TSR-011. It intends to continue to leverage the experience and competencies of its senior manageme.....



Tesaro Inc
Ticker: TSRO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 339 970-0900
Fax:
Address: 1000 Winter Street
Suite 3300
Waltham, MA 02451 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Leon MoulderCEO/Director/Co-Founder
Timothy PearsonCFO/Chief Accounting Officer/Executive VP
See More
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. It has in-licensed and are currently developing two product candidates, rolapitant and TSR-011. It intends to continue to leverage the experience and competencies of its senior manageme.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: